Shane Freake
About Shane Freake
Shane Freake is a Therapeutic Development Specialist at Bristol Myers Squibb in Ottawa, ON, Canada, with extensive experience in oncology and hematology.
Title
Shane Freake serves as a Therapeutic Development Specialist at Bristol Myers Squibb, stationed in Ottawa, Ontario, Canada. His current role focuses on developing therapies and driving innovative solutions in therapeutic spaces.
Company
Shane Freake is currently employed by Bristol Myers Squibb. The company is known for its significant contributions to pharmaceutical innovation, focusing on discovering and delivering transformative medicines to patients. At the Ottawa location, Freake is involved in therapeutic development, leveraging his extensive experience to benefit the company's therapeutic initiatives.
Previous Experience at Celgene
From 2014 to 2019, Shane Freake worked at Celgene as a Therapeutic Development Specialist in Oncology and Hematology. During his five-year tenure, he gained substantial experience in developing therapies specific to cancer and blood disorders, enhancing his expertise in these critical areas.
Previous Experience at Bristol-Myers Squibb
Before his tenure at Celgene, Shane Freake spent 15 years at Bristol-Myers Squibb as a Pharmaceutical Sales Representative specializing in Immuno-Oncology, Oncology, and Hematology. From 1999 to 2014, he honed his skills in pharmaceutical sales, focusing on selling and promoting medications designed to treat cancer and blood disorders.
Education and Expertise
Shane Freake studied at Memorial University of Newfoundland, where he obtained a Bachelor of Science (BSc) in Mathematics from 1980 to 1985. His educational background in mathematics has provided him with analytical and problem-solving skills that are pivotal in his role as a Therapeutic Development Specialist.